Medicare Enrolled
Dr. Srikar Malireddy, MD
Internal Medicine · Wichita Falls, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Malireddy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Malireddy?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Malireddy
Dr. Srikar Malireddy is an internal medicine specialist in Wichita Falls, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Malireddy performed 386,783 Medicare services across 8,813 unique beneficiaries.
Between the years covered by Open Payments, Dr. Malireddy received a total of $11,330 from 41 pharmaceutical and/or device companies across 113 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Malireddy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 0% volume in TX
$11,330 industry payments
Medicare Practice Summary
Medicare Utilization ↗386,783
Medicare services
Top 0% in TX for internal medicine
8,813
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~21,488 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 216,240 | $0 | $5 |
| Filgrastim injection (Nivestym) for white blood cells | 37,920 | $0 | $2 |
| Darbepoetin injection (Aranesp) for anemia | 23,680 | $2 | $20 |
| Pembrolizumab injection (Keytruda) | 20,400 | $43 | $137 |
| Oxaliplatin chemotherapy injection | 18,680 | $0 | $33 |
| Azacitidine chemotherapy injection | 14,200 | $0 | $13 |
| Contrast dye for imaging (iodine-based) | 13,862 | $0 | $3 |
| Iron sucrose injection (Venofer) | 6,800 | $0 | $2 |
| Anti-nausea injection (fosaprepitant) | 6,000 | $0 | $5 |
| Dexamethasone injection (steroid) | 2,851 | $0 | $1 |
| Blood draw (venipuncture) | 2,613 | $8 | $20 |
| Complete blood count (CBC) with differential | 2,338 | $8 | $36 |
| Injection, atropine sulfate, 0.01 mg | 2,200 | $0 | $1 |
| Comprehensive metabolic blood panel | 1,941 | $10 | $64 |
| Ferritin level test (iron stores) | 1,463 | $13 | $60 |
| Iron level test | 1,461 | $6 | $27 |
| Iron binding capacity test | 1,461 | $9 | $35 |
| Injection, leucovorin calcium, per 50 mg | 1,024 | $3 | $25 |
| Injection, granisetron hydrochloride, 100 mcg | 840 | $0 | $24 |
| Office visit, established patient (20-29 min) | 820 | $60 | $250 |
| Injection, fluorouracil, 500 mg | 778 | $2 | $13 |
| Injection of additional new drug or substance into vein | 635 | $12 | $108 |
| Anti-nausea injection (Aloxi/palonosetron) | 630 | $1 | $114 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 594 | $47 | $313 |
| Magnesium level test | 537 | $7 | $29 |
| Office visit, established patient (30-39 min) | 503 | $92 | $368 |
| Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 468 | $85 | $1,348 |
| Administration of chemotherapy into vein, 1 hour or less | 459 | $98 | $707 |
| Drug injection, under skin or into muscle | 350 | $10 | $96 |
| Injection, zoledronic acid, 1 mg | 302 | $6 | $431 |
| Injection, carboplatin, 50 mg | 280 | $2 | $300 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 277 | $3 | $373 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 246 | $54 | $211 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 242 | $22 | $157 |
| Complete blood count (CBC), automated | 231 | $6 | $34 |
| Microscopic examination for white blood cells with manual cell count | 228 | $4 | $22 |
| Injection, magnesium sulfate, per 500 mg | 158 | $1 | $6 |
| Administration of additional new drug or substance into vein, 1 hour or less | 150 | $49 | $344 |
| Injection, diphenhydramine hcl, up to 50 mg | 143 | $1 | $7 |
| Ct scan of chest with contrast | 130 | $48 | $821 |
| Administration of chemotherapy into vein, each additional hour | 129 | $21 | $161 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 124 | $339 | $1,722 |
| CT scan of abdomen and pelvis with contrast | 122 | $167 | $1,067 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 115 | $272 | $2,762 |
| New patient office visit (45-59 min) | 109 | $118 | $565 |
| Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 109 | $69 | $70 |
| Lactate dehydrogenase (enzyme) level | 103 | $6 | $31 |
| Irrigation of implanted venous access drug delivery device | 99 | $16 | $114 |
| PSA test (prostate cancer screening) | 96 | $18 | $94 |
| Carcinoembryonic antigen (cea) protein level | 95 | $19 | $99 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 95 | $15 | $100 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 94 | $25 | $145 |
| New patient office visit (30-44 min) | 90 | $75 | $372 |
| Office visit, established patient (10-19 min) | 88 | $39 | $150 |
| Red blood count, automated test | 82 | $4 | $23 |
| Administration of additional new drug or substance into vein using push technique | 81 | $41 | $289 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 76 | $90 | $657 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 76 | $122 | $500 |
| Unclassified drugs | 75 | $1 | $8 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 71 | $15 | $94 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 68 | $1,109 | $4,802 |
| Vitamin B-12 level test | 60 | $14 | $76 |
| Blood creatinine level | 59 | $5 | $31 |
| Phosphate level test | 59 | $5 | $24 |
| CT scan of chest, without contrast | 41 | $34 | $686 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 41 | $178 | $700 |
| Infusion, normal saline solution , 1000 cc | 40 | $2 | $19 |
| Application of on-body injector for under skin injection | 39 | $14 | $96 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 35 | $1 | $17 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 33 | $1 | $19 |
| Ct scan of abdomen and pelvis without contrast | 31 | $81 | $560 |
| Drawing of blood for a medical problem | 30 | $68 | $264 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 27 | $4 | $25 |
| Infusion into a vein for hydration, each additional hour | 25 | $10 | $75 |
| Hospital follow-up visit, moderate complexity | 25 | $61 | $247 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | 25 | $177 | $700 |
| Hospital follow-up visit, high complexity | 21 | $85 | $357 |
| Basic metabolic blood panel | 19 | $8 | $49 |
| Infusion into a vein for hydration, 31-60 minutes | 18 | $22 | $256 |
| Initial hospital admission, moderate complexity | 12 | $100 | $470 |
| Office visit, established patient, complex (40-54 min) | 11 | $137 | $496 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
56.2% high complexity
39.8% medium
3.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,330
Total received (2018-2024)
Avg $1,619/year across 7 years
Top 8% in TX for internal medicine
41
Companies
113
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,463 (65.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,159 (27.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$708 (6.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$442
2023
$2,133
2022
$4,562
2021
$200
2020
$2,566
2019
$586
2018
$842
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$7,567
Astellas Pharma US Inc
$531
Celgene Corporation
$278
PFIZER INC.
$240
E.R. Squibb & Sons, L.L.C.
$189
Novartis Pharmaceuticals Corporation
$182
Exelixis Inc.
$166
Incyte Corporation
$145
Seattle Genetics, Inc.
$131
Adaptive Biotechnologies Corporation
$128
Takeda Pharmaceuticals U.S.A., Inc.
$128
Pharmacosmos Therapeutics Inc.
$125
Merck Sharp & Dohme LLC
$122
Janssen Biotech, Inc.
$120
Janssen Scientific Affairs, LLC
$119
Karyopharm Therapeutics Inc.
$114
GlaxoSmithKline, LLC.
$101
Gilead Sciences, Inc.
$96
Clovis Oncology, Inc.
$95
Genmab U.S., Inc.
$76
Bayer HealthCare Pharmaceuticals Inc.
$73
PUMA BIOTECHNOLOGY, INC.
$71
GENZYME CORPORATION
$65
Kite Pharma, Inc.
$51
Eisai Inc.
$50
ABBVIE INC.
$45
Seagen Inc.
$43
Sun Pharmaceutical Industries Inc.
$37
Pharmacyclics LLC, An AbbVie Company
$26
Acrotech Biopharma LLC
$24
Pharmacyclics LLC, an AbbVie Company
$23
Foundation Medicine, Inc.
$22
ADC Therapeutics America, Inc.
$21
Secura Bio, Inc.
$20
CTI BioPharma Corp.
$18
Regeneron Healthcare Solutions, Inc.
$18
Tempus AI, Inc
$18
Ipsen Biopharmaceuticals, Inc
$16
AVEO Pharmaceuticals, Inc.
$15
Amgen Inc.
$13
Rigel Pharmaceuticals, Inc.
$9
Top 3 companies account for 73.9% of total payments
Associated products mentioned in payments ›
ADCETRIS · BELEODAQ · BOSULIF · CABOMETYX · CALQUENCE · Cabometyx · DARZALEX · DAURISMO · ELIQUIS · ENJAYMO · EPKINLY · EXKIVITY · Epkinly · FOTIVDA · Fabhalta · Farydak · IMFINZI · INLYTA · INREBIC · JAKAFI · JEMPERLI · KEYTRUDA · Kyprolis · LIBTAYO · LUTATHERA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · Nubeqa · OJJAARA · OPDIVO · Odomzo · PADCEV · PLUVICTO · Pomalyst · REBLOZYL · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · TAGRISSO · Tazverik · Trodelvy · VENCLEXTA · Vonjo · WELIREG · XPOVIO · XTANDI · Xofigo · Xtandi · Yescarta · ZEJULA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (66%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 8% for internal medicine in TX.
Equivalent to $3 per 100 Medicare services performed
Geographic Context
Internal medicine physicians within 10 mi
47
Per 100K population
538.1
County median income
$71,958
Nearest hospital
KELL WEST REGIONAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Malireddy is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), with consulting-driven industry engagement in the top 8% of TX peers, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Malireddy experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Malireddy performed 216,240 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Malireddy receive payments from pharmaceutical companies?
Yes. Dr. Malireddy received a total of $11,330 from 41 companies across 113 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Malireddy's costs compare to other internal medicine physicians in Wichita Falls?
Dr. Malireddy's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Malireddy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Wichita Falls
Browse internal medicine physicians in Wichita Falls ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology